Patents by Inventor R. Webb

R. Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10752913
    Abstract: The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: August 25, 2020
    Assignee: Dow AgroSciences LLC
    Inventors: Justin M. Lira, Terry R. Wright, Sean M. Russell, Donald J. Merlo, Steven R. Webb, Nicole L. Arnold, Andrew E. Robinson, Kelley A. Smith
  • Patent number: 10722515
    Abstract: The disclosure generally relates to substituted purine analogs that are dual CLK2/CDK1 inhibitors or more potent and specific CLK inhibitors to target CLK2 and CDK1 kinases. These compounds may be useful in the treatment of germ-line mutations of the spliceosome leading to the development of cancers and other human disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: July 28, 2020
    Assignee: SRI International
    Inventors: Thomas R. Webb, Jaehyeon Park, Chandraiah Lagisetti
  • Publication number: 20200191762
    Abstract: Measuring the real corrosion risk that organosulfur compounds present in refinery operations is simplified by first measuring the total sulfur content of a sample of a hydrocarbon material. The sample is then combined with a specific quantity of high surface area iron powder at a temperature representative of the highest temperature anticipated in a refining process for a period of time, such as one hour. The solid phase is then removed, and the total sulfur content is again measured. The difference between the before and after represents the total reactive sulfur of the hydrocarbon material. The hydrocarbon material is then blended with other hydrocarbon materials to create a stream that can be optimized to utilize the maximum volume of the lowest cost feedstock while managing the corrosion risk to the refinery equipment and piping.
    Type: Application
    Filed: December 12, 2019
    Publication date: June 18, 2020
    Applicant: PHILLIPS 66 COMPANY
    Inventors: Ricky E. Snelling, Omar J. Yepez, Madhu Anand, Donald R. Engelbert, Jacqueline R. Webb, Heather M. Day
  • Patent number: 10670162
    Abstract: A fluid bypass valve includes a valve member disposed within a valve chamber of a housing. A temperature based actuating mechanism moves the valve member between a first position and a second position in response to a temperature change. A temporary flow control device undergoes a one-time only shape change between a first shape and a second shape. The temporary flow control device enables fluid communication between a first port and a second port when exhibiting the first shape, and does not enable fluid communication between the first port and the second port when exhibiting the second shape. The temporary flow control device exhibits the first shape when having an initial temperature less than or equal to a second pre-defined temperature, and exhibits the second shape in response to a first heating of the temporary flow control device to a temperature that is greater than the second pre-defined temperature.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: June 2, 2020
    Assignee: GM Global Technology Operations LLC
    Inventors: Xiujie Gao, Nicholas W. Pinto, Scott R. Webb, Nilesh D. Mankame, Richard J. Skurkis
  • Patent number: 10640779
    Abstract: An Engineered Transgene Integration Platform (ETIP) is described that can be inserted randomly or at targeted locations in plant genomes to facilitate rapid selection and detection of a GOI that is perfectly targeted (both the 5? and 3? ends) at the ETIP genomic location. One element in the subject disclosure is the introduction of specific double stranded breaks within the ETIP. In some embodiments, an ETIP is described using zinc finger nuclease binding sites, but may utilize other targeting technologies such as meganucleases, CRISPRs, TALs, or leucine zippers. Also described are compositions of, and methods for producing, transgenic plants wherein the donor or payload DNA expresses one or more products of an exogenous nucleic acid sequence (e.g. protein or RNA) that has been stably-integrated into an ETIP in a plant cell. In embodiments, the ETIP facilitates testing of gene candidates and plant expression vectors from ideation through Development phases.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: May 5, 2020
    Assignee: Dow AgroSciences LLC
    Inventors: Noel Cogan, John Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg, Steven R. Webb, Manju Gupta, W. Mike Ainley, Matthew J. Henry, John Mason, Sandeep Kumar, Stephen Novak
  • Publication number: 20200087671
    Abstract: A method of gene editing or gene stacking within a FAD3 loci by cleaving, in a site directed manner, a location in a FAD3 gene in a cell, to generate a break in the FAD3 gene and then ligating into the break a nucleic acid molecule associated with one or more traits of interest is disclosed.
    Type: Application
    Filed: November 27, 2019
    Publication date: March 19, 2020
    Inventors: Noel Cogan, John Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg, Steven R. Webb, Manju Gupta, W. Michael Ainley, Matthew J. Henry, Jeffrey C. Miller, Dmitry Y. Guschin
  • Publication number: 20200071712
    Abstract: Disclosed herein are methods and compositions for parallel or sequential transgene stacking in plants to produce plants with selected phenotypes.
    Type: Application
    Filed: November 5, 2019
    Publication date: March 5, 2020
    Inventors: W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason, Jeffrey C. Miller, Joseph F. Petolino, Yidong Ran, Tim Sawbridge, German Spangenberg, Steven R. Webb
  • Patent number: 10577616
    Abstract: A method of gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a cell, to generate a break in the FAD2 gene and then ligating into the break a nucleic acid molecule associated with one or more traits of interest is disclosed.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: March 3, 2020
    Assignees: Dow AgroSciences LLC, Sangamo Therapeutics, Inc.
    Inventors: Noel Cogan, John Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg, Steven R. Webb, Manju Gupta, W. Michael Ainley, Matthew J. Henry, Jeffrey C. Miller, Dmitry Y. Guschin
  • Patent number: 10526610
    Abstract: A method of gene editing or gene stacking within a FAD3 loci by cleaving, in a site directed manner, a location in a FAD3 gene in a cell, to generate a break in the FAD3 gene and then ligating into the break a nucleic acid molecule associated with one or more traits of interest is disclosed.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: January 7, 2020
    Assignees: Dow AgroSciences LLC, Sangamo Therapeutics, Inc.
    Inventors: Noel Cogan, John Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg, Steven R. Webb, Manju Gupta, W. Michael Ainley, Matthew J. Henry, Jeffrey C. Miller, Dmitry Y. Guschin
  • Patent number: 10501748
    Abstract: Disclosed herein are methods and compositions for parallel or sequential transgene stacking in plants to produce plants with selected phenotypes.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: December 10, 2019
    Assignees: Dow AgroSciences LLC, Sangamo Therapeutics, Inc.
    Inventors: W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason, Jeffrey C. Miller, Joseph F. Petolino, Yidong Ran, Tim Sawbridge, German Spangenberg, Steven R. Webb
  • Publication number: 20190316141
    Abstract: Methods and compositions for gene disruption, gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a soybean cell, to generate a break in the FAD2 gene and then optionally integrating into the break a nucleic acid molecule of interest is disclosed.
    Type: Application
    Filed: April 23, 2019
    Publication date: October 17, 2019
    Inventors: W. Michael Ainley, Steven R. Webb, Jayakumar P. Samuel, Dmitry Y. Guschin, Jeffrey C. Miller, Lei Zhang
  • Patent number: 10415046
    Abstract: The present invention claims methods for the stable integration of exogenous DNA into a specific locus, E32, in the maize genome through the use of zinc finger nucleases. Maize plants and plant parts that were transformed by the methods of the invention are claimed. The invention is useful for creating desirable traits such as herbicide resistance, herbicide tolerance, insect resistance, insect tolerance, disease resistance, disease tolerance, stress tolerance, and stress resistance in maize The E32 locus represents a superior site for inserting foreign genes because native agronomic phenotypes are not disturbed.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: September 17, 2019
    Assignee: Dow AgroSciences LLC
    Inventors: W. Michael Ainley, James W. Bing, David R. Corbin, Steven L. Evans, Joseph F. Petolino, Lakshmi Sastry-Dent, Steven A. Thompson, Steven R. Webb, Mary E. Welter, Ning Zhou
  • Publication number: 20190255059
    Abstract: This disclosure generally relates to dual CLK2/CDK1 inhibitors or more potent and specific CLK inhibitors to target CLK2 and CDK1 kinases in the treatment of germ-line mutations of the spliceosome leading to the development of cancers and other human disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: September 29, 2017
    Publication date: August 22, 2019
    Inventors: Thomas R. Webb, Jaehyeon Park, Chandraiah Lagisetti
  • Patent number: 10344322
    Abstract: The present disclosure provides methods for detecting and identifying plant events that contain precision targeted genomic loci, and plants and plant cells comprising such targeted genomic loci. The method can be deployed as a high throughput process utilized for screening the intactness or disruption of a targeted genomic loci and optionally for detecting a donor DNA polynucleotide insertion at the targeted genomic loci. The methods are readily applicable for the identification of plant events produced via a targeting method which results from the use of a site specific nuclease.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: July 9, 2019
    Assignee: Dow AgroSciences LLC
    Inventors: Lakshmi Sastry-Dent, Matthew A. Simpson, Zehui Cao, Wei Chen, Ning Zhou, Steven R. Webb
  • Publication number: 20190194674
    Abstract: As disclosed herein, optimal native genomic loci have been identified in monocot plants, such as maize plants, that represent best sites for targeted insertion of exogenous sequences.
    Type: Application
    Filed: January 31, 2019
    Publication date: June 27, 2019
    Inventors: Lakshmi SASTRY-DENT, Zehui CAO, Shreedharan SRIRAM, Steven R. WEBB, Debra L. CAMPER, Navin ELANGO
  • Patent number: 10287595
    Abstract: Methods and compositions for gene disruption, gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a soybean cell, to generate a break in the FAD2 gene and then optionally integrating into the break a nucleic acid molecule of interest is disclosed.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: May 14, 2019
    Assignees: Dow AgroSciences LLC, Sangamo Therapeutics, Inc.
    Inventors: W. Michael Ainley, Steven R. Webb, Jayakumar P. Samuel, Dmitry Y. Guschin, Jeffrey C. Miller, Lei Zhang
  • Publication number: 20190136265
    Abstract: As disclosed herein, optimal native genomic loci have been identified in dicot plants, such as soybean plants, that represent best sites for targeted insertion of exogenous sequences.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 9, 2019
    Inventors: Lakshmi SASTRY-DENT, Zehui CAO, Shreedharan SRIRAM, Steven R. WEBB, Debra L. CAMPER
  • Patent number: 10273493
    Abstract: As disclosed herein, optimal native genomic loci have been identified in monocot plants, such as maize plants, that represent best sites for targeted insertion of exogenous sequences.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: April 30, 2019
    Assignee: Dow AgroSciences LLC
    Inventors: Lakshmi Sastry-Dent, Zehui Cao, Shreedharan Sriram, Steven R. Webb, Debra L. Camper, Navin Elango
  • Publication number: 20190085344
    Abstract: A method for producing a transgenic plant includes providing a nucleic acid molecule comprising at least two regions of nucleic acid sequence that lack sequence homology with genomic DNA of the plant cell, and at least two zinc finger nuclease recognition sites, wherein the at least two regions of nucleic acid sequence that lack sequence homology with genomic DNA of the plant cell flank the at least two zinc finger nuclease recognition sites. A plant cell or tissue having the nucleic acid molecule stably integrated into the genome of the plant cell is transformed. A plant is regenerated from the plant cell. Transgenic plants are produced by the method. Seeds are produced by the transgenic plants.
    Type: Application
    Filed: December 4, 2018
    Publication date: March 21, 2019
    Inventors: William Michael Ainley, Ryan C. Blue, Michael G. Murray, David Richard Corbin, Rebecca Ruth Miles, Steven R. Webb
  • Patent number: 10233465
    Abstract: As disclosed herein, optimal native genomic loci have been identified in dicot plants, such as soybean plants, that represent best sites for targeted insertion of exogenous sequences.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: March 19, 2019
    Assignee: Dow AgroSciences LLC
    Inventors: Lakshmi Sastry-Dent, Zehui Cao, Shreedharan Sriram, Steven R. Webb, Debra L. Camper